Vivanza Biosciences Limited has filed its audited financial results for the quarter and year ended March 31, 2026, confirming the statutory auditors have issued an unmodified opinion on the report. The disclosure ensures compliance with regulatory requirements regarding the timely announcement of financial performance.

The audit was conducted by M/S. Shivam Soni & Co, Chartered Accountants, based in Ahmedabad. The firm holds Firm Registration Number (FRN) 152477W. An unmodified opinion indicates that the financial statements present a true and fair view of the company's financial position and performance in accordance with applicable accounting standards.

The filing was submitted to BSE Limited pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates the declaration of audited financial results within a specified timeframe. The company's scrip code on the exchange is 530057.

The document was signed by Jayendra Amichand Mehta, Managing Director of Vivanza Biosciences Limited. The digital signature was verified on July 11, 2026.

Vivanza Biosciences Limited appointed CS Vishal Sureshbhai Katarmal as its Company Secretary and Compliance Officer effective July 9, 2026, to strengthen its regulatory compliance framework. The Board of Directors approved the appointment during a meeting held on July 9, 2026, pursuant to Section 203 of the Companies Act, 2013, and Regulation 6(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment Details

CS Vishal Sureshbhai Katarmal is an Associate Member of the Institute of Company Secretaries of India (ACS: 78544). He brings experience in dealing with matters of the Companies Act, Listing Regulations, and allied laws. The appointment follows the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Proceedings

The meeting of the Board of Directors commenced at 15:15 P.M. and concluded at 15:30 P.M. The disclosure was submitted to the stock exchange in compliance with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015.